Abstract | OBJECTIVE: To determine if adenocarcinoma of the Skene's glands in women, which has a histological and immunohistochemical appearance similar to prostate cancer, can be evaluated and managed with the same tools we use for prostate cancer. METHODS: RESULTS: CONCLUSION: Despite the rarity of Skene's gland adenocarcinoma, we can employ many of the tools at our disposal for the evaluation and management of prostate cancer to benefit the women found to have this malignancy.
|
Authors | Matthew E Kaufman, Devin T Miller, Asad Ullah, Joseph White, Gurmukh Singh, Ravindra Kolhe, Hadyn Williams, Pardeep Mittal, Jigarkumar Parikh, Martha K Terris |
Journal | Urology
(Urology)
Vol. 151
Pg. 182-187
(05 2021)
ISSN: 1527-9995 [Electronic] United States |
PMID | 32504685
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
Chemical References |
- Androgen Antagonists
- Antineoplastic Agents, Hormonal
- Prostate-Specific Antigen
|
Topics |
- Adenocarcinoma
(diagnostic imaging, pathology, therapy)
- Aged
- Androgen Antagonists
(therapeutic use)
- Antineoplastic Agents, Hormonal
(therapeutic use)
- Female
- Humans
- Imaging, Three-Dimensional
- Multiparametric Magnetic Resonance Imaging
- Positron-Emission Tomography
- Prostate-Specific Antigen
(blood)
- Urethral Neoplasms
(diagnostic imaging, pathology, therapy)
|